BRSK1 is a brain-enriched serine/threonine kinase essential for neuronal polarization and axon specification. It phosphorylates tau and other microtubule-associated proteins, linking cytoskeletal regulation to neuronal development and neurodegenerative disease.
[^2]
| Property | Value |
|----------|-------|
| Gene Symbol | BRSK1 |
| Full Name | Brain-Specific Serine/Threonine-Protein Kinase 1 |
| Aliases | SAD-B, SADB, brain-selective kinase 1 |
| Chromosomal Location | 19q13.42 |
| NCBI Gene ID | 84446 |
| OMIM ID | 609235 |
| Ensembl ID | ENSG00000160469 |
| UniProt ID | Q8TDC3 |
| Encoded Protein | BRSK1 Protein |
| Associated Diseases | Alzheimer's disease, tauopathies, neurodevelopmental disorders |
BRSK1 (Brain-Specific Serine/Threonine-Protein Kinase 1), also known as SAD-B (synapses of amphids defective), is a member of the AMPK-related kinase family. It was first identified in C. elegans as a kinase required for presynaptic vesicle clustering and subsequently shown to be critical for mammalian neuronal polarization. BRSK1 and its paralog BRSK2 are among the most brain-enriched kinases in the mammalian genome, and their combined activity is essential for axon-dendrite specification during cortical development. BRSK1 phosphorylates tau at KXGS motifs and regulates microtubule dynamics, placing it at the intersection of normal neuronal development and neurodegenerative tau pathology.
¶ Neuronal Polarization and Axon Specification
BRSK1 is one of the master regulators of neuronal polarity:
- Axon determination — BRSK1 is activated by LKB1/STK11 at the nascent axon tip; its local activation triggers the symmetry-breaking event that converts one neurite into the axon
- SAD kinase function — In C. elegans, the SAD-1 ortholog clusters synaptic vesicles at presynaptic terminals; mammalian BRSK1 retains this function while gaining additional polarity roles
- Double knockout phenotype — BRSK1/BRSK2 double knockout mice fail to develop axons entirely, demonstrating the essential nature of these kinases for neuronal polarization
- Microtubule reorganization — BRSK1 phosphorylates MAPs to promote the transition from mixed to uniformly plus-end-out microtubule polarity in the nascent axon
- Axon initial segment — BRSK1 contributes to establishing the axon initial segment (AIS), the specialized domain that separates axonal from somatodendritic compartments
BRSK1 is a physiologically relevant tau kinase:
- KXGS motif phosphorylation — Phosphorylates tau at Ser262 and Ser356 within microtubule-binding repeats, similar to MARK kinases
- Microtubule detachment — BRSK1-mediated tau phosphorylation reduces tau-microtubule affinity, creating dynamic microtubule regions necessary for axon growth
- Developmental timing — BRSK1 tau phosphorylation is highest during embryonic neuronal development (E13-E18), then decreases postnatally as stable microtubule arrays form
- Cooperative phosphorylation — BRSK1 can prime tau for subsequent phosphorylation by GSK3β and CDK5
BRSK1 regulates presynaptic function:
- Vesicle clustering — Phosphorylates substrates at presynaptic terminals that organize synaptic vesicle pools
- Active zone organization — Contributes to the spatial organization of neurotransmitter release sites
- Synaptic transmission — BRSK1 deficiency leads to impaired synaptic vesicle cycling and reduced neurotransmitter release
- LKB1 activation — The primary activating kinase; LKB1 phosphorylates BRSK1 at Thr189 in the activation loop
- 14-3-3 binding — Phosphorylated BRSK1 associates with 14-3-3 proteins, which modulate its subcellular localization
- Calcium regulation — BRSK1 activity may be modulated by calcium-dependent signaling in neurons
- Lipid binding — The C-terminal UBA domain and kinase-associated domain contribute to membrane targeting
BRSK1 is implicated in AD through tau-dependent mechanisms:
- Tau hyperphosphorylation — Aberrant reactivation of BRSK1 in mature neurons may contribute to pathological tau phosphorylation at Ser262, one of the earliest modified sites in AD
- Developmental kinase reactivation — The "developmental recapitulation" hypothesis proposes that kinases normally active during embryonic neuronal polarization (including BRSK1) become reactivated in AD, driving tau pathology
- Expression changes — BRSK1 expression and activity are altered in AD brain tissue, particularly in hippocampal and entorhinal cortical neurons
- Synapse loss — BRSK1 dysregulation may contribute to presynaptic dysfunction and synapse loss, a hallmark correlate of cognitive decline in AD
- Progressive supranuclear palsy — BRSK1 may contribute to 4R-tau pathology characteristic of PSP
- Corticobasal degeneration — Elevated BRSK activity has been reported in CBD brain tissue
- MAPT mutations — FTD-causing MAPT mutations may alter tau's susceptibility to BRSK1 phosphorylation
- Cortical malformations — Given BRSK1's essential role in neuronal polarization, loss-of-function variants may cause cortical development defects
- Intellectual disability — Rare variants in BRSK1 have been identified in cases of intellectual disability with structural brain abnormalities
- Autism spectrum disorder — BRSK1 is expressed in brain regions affected in ASD, and polarity defects may contribute to cortical connectivity abnormalities
BRSK1 contains several functional domains essential for its kinase activity:
¶ Kinase Domain
- Catalytic core: Contains the active site for ATP binding and phosphoryl transfer
- Activation loop: Thr189 phosphorylation by LKB1 is required for activity
- Substrate recognition: Specific residues recognize tau and other MAPs
¶ Regulatory Domains
- UBA domain: Ubiquitin-associated domain at C-terminus
- KA1 domain: Kinase-associated domain involved in membrane targeting
- Helical linker: Connects kinase domain to regulatory regions
Targeting BRSK1 therapeutically requires understanding its dual role:
| Approach |
Strategy |
Challenge |
| Inhibition |
Block pathological tau phosphorylation |
May disrupt neuronal development |
| Activation |
Enhance protective signaling |
Need cell-type specificity |
| Modulation |
Fine-tune activity levels |
Therapeutic window |
BRSK1 as a biomarker:
- Activity markers: Phospho-Thr189 levels indicate activation status
- Expression changes: Altered levels in AD brain tissue
- Genetic variants: Disease-associated polymorphisms
- CRISPR knockout: Studying loss-of-function phenotypes
- Phospho-antibodies: Detecting specific phosphorylation sites
- Kinase assays: Measuring catalytic activity
- Primary neurons: Primary cortical neuron cultures
- iPSC-derived neurons: Disease modeling potential
- Organoid systems: Three-dimensional brain models
- Knockout mice: BRSK1/BRSK2 double knockout
- Conditional knockouts: Cell-type-specific deletion
- Behavioral analysis: Cognitive and motor function
BRSK1 has highly brain-enriched expression:
- Brain regions — Strongly expressed in hippocampus, cerebral cortex, cerebellum, and olfactory bulb; lower expression in brainstem and spinal cord
- Cell types — Predominantly neuronal; minimal expression in astrocytes or microglia
- Developmental expression — Peaks during embryonic cortical neurogenesis (E13-E18 in mouse); maintained at lower levels in adult brain
- Subcellular localization — Axonal growth cones during development; presynaptic terminals in mature neurons
- Tissue specificity — Among the most brain-specific kinases; very low expression in non-neural tissues
- Allen Brain Atlas — BRSK1 expression data